Latest News and Events
Filter by
Selections
December 20, 2012
Arrowhead Reports Fiscal 2012 Fourth Quarter and Year-End Financial Results
Read MoreDecember 18, 2012
Arrowhead and Shire Enter into Collaboration and License Agreement to Develop Peptide-Targeted Therapeutics
Read MoreDecember 14, 2012
Arrowhead to Report Fiscal 2012 Fourth Quarter and Year-End Financial Results
Read MoreDecember 7, 2012
Arrowhead Announces Pricing of a Public Offering of Common Stock and Warrants
Read MoreNovember 27, 2012
Arrowhead Publishes First Ever Cholesterol-siRNA Mediated Gene Knockdown in Primates and Novel DPC Co-Injection Strategy
Read MoreNovember 13, 2012
Arrowhead Creates Hepatitis B Clinical Advisory Board and Names Dr. Robert Gish Chairman
Read MoreOctober 29, 2012
Arrowhead Presents Data Showing 99% Target Knockdown in Monkeys Without Toxicity Using Subcutaneous Formulation of Dynamic Polyconjugate siRNA Delivery System
Read MoreOctober 16, 2012